Boston Commerce Limited vs Nephro Care India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Boston Commerce Limited is ₹ 10.43 as of 23 Oct 15:30 . The P/E Ratio of Boston Commerce Limited is 0 as of March 2026 .The P/E Ratio of Nephro Care India Ltd is 25.4 as of March 2026 . The Market Cap of Boston Commerce Limited is ₹ 0 crore as of March 2026 .The Market Cap of Nephro Care India Ltd is ₹ 85.32 crore as of March 2026 . The Revenue of Boston Commerce Limited is ₹ 0 crore as of Jun '25 .The Revenue of Nephro Care India Ltd is ₹ 17.39 crore as of Jun '25 . The EBITDA of Boston Commerce Limited is ₹ 0 crore as of Jun '25 .The EBITDA of Nephro Care India Ltd is ₹ 0.66 crore as of Jun '25 . The Net Profit of Boston Commerce Limited is ₹ 0 crore as of Jun '25 .The Net Profit of Nephro Care India Ltd is ₹ -0.65 crore as of Jun '25 . The Dividend Payout of Boston Commerce Limited changed from 0 % on March 2022 to 0 % on March 2021 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Nephro Care India Ltd changed from 0 % on March 2022 to 0 % on March 2021 . This represents a CAGR of 0.0% over 6 years .

About Boston Commerce Limited

Boston Bio Systems Limited was incorporated on April 17, 1995.
Initially, Company was engaged in share broking.
Presently, it trades in medical equipment, testing kits and instruments.
The Company specialize in jobworking for herbal and health-related products, partnering with businesses to bring their formulations and ideas to life.
With a strong foundation in natural wellness, Company is providing high-quality, custom solutions to the growing demand for herbal products and health supplements. Apart from these, Company provide custom buffers to keep the projects running seamlessly.

About Nephro Care India Ltd

Nephro Care India Limited was originally incorporated on July 08, 2014 as a Private Limited Company as 'Nephro Care India Private Limited' with the Registrar of Companies, West Bengal.
Subsequently, Company converted into a Public Limited Company and the name of Company was changed to Nephro Care India Limited' and a fresh Certificate of Incorporation dated March 5, 2024, was issued by the Registrar of Companies, Central Processing Centre. Nephro Care was founded in the year 2014 by Dr. Pratim Sengupta in Kolkata with an object of providing comprehensive medical services for renal patients.
The Company is a one stop treatment centre based in Kolkata that offer clinical and lifestyle solutions and services and renal insufficiency treatment to patients.
The treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness.

FAQs for the comparison of Boston Commerce Limited and Nephro Care India Ltd

Which company has a larger market capitalization, Boston Commerce Limited or Nephro Care India Ltd?

Market cap of Boston Commerce Limited is 7 Cr while Market cap of Nephro Care India Ltd is 136 Cr

What are the key factors driving the stock performance of Boston Commerce Limited and Nephro Care India Ltd?

The stock performance of Boston Commerce Limited and Nephro Care India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Boston Commerce Limited and Nephro Care India Ltd?

As of October 25, 2026, the Boston Commerce Limited stock price is INR ₹10.43. On the other hand, Nephro Care India Ltd stock price is INR ₹83.0.

How do dividend payouts of Boston Commerce Limited and Nephro Care India Ltd compare?

To compare the dividend payouts of Boston Commerce Limited and Nephro Care India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.